logo
Select company
Select metric
$ 13.99MNet Cash Flow - Financing
VS
Market
30
Sector
37
Industry
45
History
30
$ 5.06Close
$ 4.98 - $ 37.65 52-Week Range
Ticker Information

Ticker

IMNN

Company Name

IMUNON INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

IMUNON INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IMNN - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 13.99M
3/31/2025$ 9.17M
12/31/2024$ 9.06M
9/30/2024$ 9.09M
6/30/2024$ 108.51K
3/31/2024$ -6.11M
12/31/2023$ -3.64M
9/30/2023$ -3.22M
6/30/2023$ -3.36M
3/31/2023$ 9.2M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • IMUNON INC's latest trailing twelve months (TTM) CF - Financing stands at $ 17.11M.
  • Over the past 5 years, IMUNON INC's average CF - Financing has been $ 16.1M.
  • The median CF - Financing for IMUNON INC during this period was $ 9.13M
  • IMUNON INC reached its highest CF - Financing over the past 5 years at $ 57.33M.
  • The lowest CF - Financing recorded by IMUNON INC in the same timeframe $ -6.11M

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

IMNN - Net Cash Flow - Financing, Last 5 years

$ -6.11M

Minimum

Mar 31, 2024

$ 57.33M

Maximum

Sep 30, 2021

$ 16.1M

Average

$ 9.13M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.84M with a standard deviation of $ 119.27M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.22K
min$ -367.1M
max$ 366M
average$ -6.84M
median$ 305K
std$ 119.27M